BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Deferred Tax Liabilities
Taxes owed in future periods because of timing differences between accounting and tax rules.
BillionToOne, Inc.NASDAQ: BLLN
Deferred Tax Liabilities · Q2 FY2026 · quarter ended Jun 2026
Deferred tax liabilities remains negative
Q2 FY2026 deferred tax liabilities was $0, compared with $0 a year earlier.
Context
- Deferred tax liabilities amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Deferred tax liabilities increased in 0 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Tax Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Tax Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
Deferred Tax Liabilities vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 deferred tax liabilities of $0 is the 7th highest of the 9 companies compared; the peer median is $787K.
- Deferred tax liabilities amounts to 0.0% of total assets for BLLN, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $133.71M | -49.8% | -33.3% | 4.7% | |
| Jun 2026 | $16.82M | -15.8% | -19.4% | 1.2% | |
| Mar 2026 | $12.71M | +103.8% | — | 1.1% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $873K | +16.9% | -6.1% | 0.2% |
| Jun 2026 | $701K | — | — | 0.0% | |
| Jun 2026 | $637K | -51.0% | -47.8% | 0.0% | |
BLLNBillionToOne, Inc. | Jun 2026 | $0 | — | — | 0.0% |
| Sep 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding BLLN) | $787K | -15.8% | -26.3% | 0.1% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.